Basel Medical Group Ltd logo

Basel Medical Group Ltd (BMGL)

Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 58
-0.01
-1.4653%
Pre Market
$
0. 56
-0.02 -3.7005%
11.03M Market Cap
- P/E Ratio
- Div Yield
73,410 Volume
- Eps
$ 0.59
Previous Close
Investors:
Add Transaction
Day Range
0.5 0.58
Year Range
0.38 4.85
Want to track BMGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming BMGL split of 1:12 in 10 days (22 Jun 2026)

Summary

BMGL closed today lower at $0.58, a decrease of -1.4653% from yesterday's close, completing a monthly decrease of -6.5751% or -$0.04. Over the past 12 months, BMGL stock gained 18.0204%.
BMGL is not paying dividends to its shareholders.
Basel Medical Group Ltd has a scheduled stock split on Jun 22, 2026 for a 1:12 split ratio, meaning every BMGL investor will receive 1.0 shares for every 12.0 existing shares.
The stock of the company had never split.
The company's stock is traded on one exchange.

BMGL Chart

People also search for

Estrella Immunopharma Inc.
$ 1.08
+1.8868%
Kalaris Therapeutics, Inc.
$ 4.72
+1.5054%
PolyPid Ltd.
$ 4.57
+1.3304%
Lantern Pharma Inc.
$ 4.07
+4.8969%
Eloxx Pharmaceuticals, Inc.
$ 12.64
+14.9091%

Basel Medical Group Ltd Investors

Name Quantity Cost Value Profit ($) Gain (%)
BB
Brian Baylis Bell Investment Advisors Inc.
248 $451.36 $138.88 -$312.48 -69.23%

Basel Medical Group Ltd (BMGL) FAQ

What is the stock price today?

The current price is $0.58.

On which exchange is it traded?

Basel Medical Group Ltd is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is BMGL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 11.03M.

Has Basel Medical Group Ltd ever had a stock split?

No, there has never been a stock split.

Basel Medical Group Ltd Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Yen Feng Chhoa CEO
NASDAQ (CM) Exchange
G0864B103 CUSIP
SG Country
32 Employees
- Last Dividend
22 Jun 2026 Last Split
- IPO Date

Overview

Basel Medical Group Ltd is a dynamic healthcare provider established in 2023. Headquartered in Singapore, the company specializes in a broad range of healthcare services aimed at enhancing patient care and accessibility. Basel Medical Group is dedicated to offering innovative solutions across several medical domains, including medical specialist services, medical supplies and equipment, medical technology advancements, and pharmaceuticals. With a commitment to advancing healthcare standards, the company strives to support both healthcare providers and patients in achieving better health outcomes.

Products and Services

  • Medical Specialists

    Basel Medical Group collaborates with a network of experienced medical specialists across various fields. These experts provide comprehensive consultations and treatment options tailored to meet the needs of patients, ensuring quality care in areas such as cardiology, pediatrics, orthopedics, and more.

  • Medical Supplies and Equipment

    The company offers a wide array of medical supplies and equipment essential for healthcare operations. This includes surgical instruments, diagnostic tools, and various medical consumables, all sourced from reputable manufacturers to guarantee reliability and safety for healthcare providers and their patients.

  • Medical Technology

    Basel Medical Group is focused on incorporating cutting-edge medical technology into its services. This includes advanced health information systems, telemedicine solutions, and innovative medical devices that enhance diagnostic accuracy and treatment effectiveness, thereby streamlining healthcare delivery.

  • Pharmaceuticals

    The company provides a comprehensive range of pharmaceutical products, offering everything from over-the-counter medications to prescription drugs for various health conditions. Basel Medical Group emphasizes the importance of quality control and regulatory compliance in its pharmaceutical services, ensuring that all products meet the highest safety standards.

Contact Information

Address: 600 North Bridge Road
Phone: 65 6291 9188